Type to search

Cardiovascular Diseases Industry News Partnerships

MediCardia Health Inc. Integrates Optimize EP C-aRM to Develop First of it’s Kind, Comprehensive Connected Cardiac Care Platform

MediCardia Health Inc. Integrates Optimize EP C-aRM to Develop First of it's Kind, Comprehensive Connected Cardiac Care Platform | Pharmtech Focus

MediCardia Health Inc., a pioneer in global digital health, announced today that the Company has completed integration with Optimize EP‘s CaRM CIED (cardiovascular implantable electronic device) platform. The combined platform will comprise the worlds 1st comprehensive connected cardiac care platform for management of patients chronic cardiovascular conditions and cardiac implanted devices. As a partner, Optimize EP will provide comprehensive CIED data to support the MediCardia Virtuas remote and virtual care platform. Both companies have agreed to comarket and co-sell their products as a single platform.

“We believe in the 3P’s of medicine—predictive, preventive, and personalized—and it motivates us every day to gain deeper cardiology and AI expertise and create smarter technical solutions,” said Ravi Kartan, President, and CEO of Optimize EP. “MediCardia’s in-depth experience makes them an ideal partner for Optimize EP. Together we are developing applications that will promote long and healthy life.”

With the integration of comprehensive CIED data, MediCardia Health continues to lead the industry in cardiovascular data interoperability and visualization. Providers can view multiple data streams across workflows simultaneously, including:

  • Remote patient monitoring (RPM) of vital signs
  • Chronic care management
  • Principal Care Management
  • CIED data management with the OptimizeEP C-aRM integration

“Leveraging EMR integration, data typically trapped in unstructured text is discretized using Natural Language Processing and Machine Learning technologies. This ‘context’ enables correlations to be made instantly and effectively, shortening time to diagnosis and provider action” said Indrajit Choudhuri, M.D., CEO of MediCardia Health.


People in this post:

Companies in this post:

Next Up